Castellano Leandro, Giamas Georgios, Jacob Jimmy, Coombes R Charles, Lucchesi Walter, Thiruchelvam Paul, Barton Geraint, Jiao Long R, Wait Robin, Waxman Jonathan, Hannon Gregory J, Stebbing Justin
Department of Oncology, Cyclotron Building, Hammersmith Hospital Campus, Imperial College, Du Cane Road, London W12 0NN, United Kingdom.
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15732-7. doi: 10.1073/pnas.0906947106. Epub 2009 Aug 24.
Following estrogenic activation, the estrogen receptor-alpha (ERalpha) directly regulates the transcription of target genes via DNA binding. MicroRNAs (miRNAs) modulated by ERalpha have the potential to fine tune these regulatory systems and also provide an alternate mechanism that could impact on estrogen-dependent developmental and pathological systems. Through a microarray approach, we identify the subset of microRNAs (miRNAs) modulated by ERalpha, which include upregulation of miRNAs derived from the processing of the paralogous primary transcripts (pri-) mir-17-92 and mir-106a-363. Characterization of the mir-17-92 locus confirms that the ERalpha target protein c-MYC binds its promoter in an estrogen-dependent manner. We observe that levels of pri-mir-17-92 increase earlier than the mature miRNAs derived from it, implicating precursor cleavage modulation after transcription. Pri-mir-17-92 is immediately cleaved by DROSHA to pre-miR-18a, indicating that its regulation occurs during the formation of the mature molecule from the precursor. The clinical implications of this novel regulatory system were confirmed by demonstrating that pre-miR-18a was significantly upregulated in ERalpha-positive compared to ERalpha-negative breast cancers. Mechanistically, miRNAs derived from these paralogous pri-miRNAs (miR-18a, miR-19b, and miR-20b) target and downregulate ERalpha, while a subset of pri-miRNA-derived miRNAs inhibit protein translation of the ERalpha transcriptional p160 coactivator, AIB1. Therefore, different subsets of miRNAs identified act as part of a negative autoregulatory feedback loop. We propose that ERalpha, c-MYC, and miRNA transcriptional programs invoke a sophisticated network of interactions able to provide the wide range of coordinated cellular responses to estrogen.
雌激素激活后,雌激素受体α(ERα)通过与DNA结合直接调控靶基因的转录。由ERα调控的微小RNA(miRNA)有可能对这些调控系统进行微调,并且还提供了一种可能影响雌激素依赖性发育和病理系统的替代机制。通过微阵列方法,我们鉴定了受ERα调控的miRNA子集,其中包括来自同源初级转录本(pri-)mir-17-92和mir-106a-363加工过程产生的miRNA的上调。对mir-17-92基因座的表征证实,ERα靶蛋白c-MYC以雌激素依赖性方式结合其启动子。我们观察到pri-mir-17-92的水平比从中衍生的成熟miRNA升高得更早,这表明转录后前体切割受到调控。Pri-mir-17-92立即被DROSHA切割成pre-miR-18a,表明其调控发生在从前体形成成熟分子的过程中。通过证明与ERα阴性乳腺癌相比,pre-miR-18a在ERα阳性乳腺癌中显著上调,证实了这种新型调控系统的临床意义。从机制上讲,来自这些同源pri-miRNA的miRNA(miR-18a、miR-19b和miR-20b)靶向并下调ERα,而pri-miRNA衍生的miRNA子集中的一部分抑制ERα转录共激活因子p160的蛋白翻译。因此,鉴定出的不同miRNA子集作为负自调节反馈环的一部分发挥作用。我们提出,ERα、c-MYC和miRNA转录程序引发了一个复杂的相互作用网络,能够对雌激素提供广泛的协调细胞反应。